U.S. flag An official website of the United States government
  1. Home
  2. About FDA
  3. FDA Organization
  4. Center for Drug Evaluation and Research | CDER
  5. CDER Offices and Divisions
  6. Office of Neuroscience - Division of Anesthesiology, Addiction Medicine, and Pain Medicine (DAAP)
  1. CDER Offices and Divisions

Office of Neuroscience - Division of Anesthesiology, Addiction Medicine, and Pain Medicine (DAAP)


The Division of Anesthesia, Addiction Medicine and Pain Medicine (DAAP) regulates and reviews Investigational New Drug (IND) applications and marketing applications for drug and biologic products for the treatment of Acute Pain, e.g. Surgical and procedural pain, pain due to trauma/injury, pain due to acute inflammatory processes; Chronic pain, e.g.: cancer pain, neuropathic pain, fibromyalgia, osteoarthritis pain, low back pain and addiction, e.g.: nicotine, alcohol, stimulants, opioids. DAAP also regulates the drug product classes that are used in surgical, procedural or ICU settings to provide patient comfort and/or ease of treatment, e.g.: general anesthetics, local anesthetics, dental anesthetics, topical anesthetics, neuromuscular-blocking agents and neuromuscular-blocker reversal agents.

The Division of Anesthesiology, Addiction Medicine, and Pain Medicine regulates and reviews Investigational New Drug Applications (INDs), New Drug Applications (NDAs), and Biologics Licensing Applications (BLAs) for prescription drugs and biologics intended for the prevention, treatment, or diagnosis of conditions including:

  • Acute Pain, e.g.:
    • Surgical and procedural pain
    • Pain due to trauma/injury
    • Pain due to acute inflammatory processes
  • Chronic pain, e.g.:
    • Cancer pain
    • Neuropathic pain
    • Fibromyalgia
    • Osteoarthritis Pain
    • Low back pain
  • Addiction, e.g.:
    • Nicotine
    • Alcohol
    • Stimulants
    • Opioids

DAAP also regulates the drug product classes that are used in surgical, procedural or ICU settings to provide patient comfort and/or ease of treatment, e.g.:

  • General anesthetics
  • Local anesthetics
  • Dental anesthetics
  • Topical anesthetics
  • Neuromuscular-blocking agents and neuromuscular-blocker reversal agents

Contact Us

Mailing Address

Food and Drug Administration
Center for Drug Evaluation and Research
Division of Anesthesiology, Addiction Medicine, and Pain Medicine (DAAP)
5901-B Ammendale Road
Beltsville, MD 20705-1266
Phone: (301) 796-2280
Fax: (301) 837-6231

OND Office and Division Contact Information (PDF)

Resources For You




 
Back to Top